Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 16.20
+0.02 (0.12%)
May 7, 2026, 4:08 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 18.5 billion as of May 7, 2026. Its market cap has decreased by -33.27% in one year.
Market Cap
18.50B
Enterprise Value
14.85B
Revenue
3.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
16.20
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 18.50B, an increase of 1,261.28%. That is a compound annual growth rate of 35.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 18.50B | 21.12% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 29.69B |
| InnoCare Pharma | 27.77B |
| Duality Biotherapeutics | 24.31B |
| Keymed Biosciences | 21.46B |
| TransThera Sciences (Nanjing) | 21.01B |
| Ascletis Pharma | 17.74B |
| Ascentage Pharma Group International | 15.78B |
| Nanjing Leads Biolabs | 15.41B |